MIRA Pharmaceuticals (MIRA) Competitors $1.20 -0.06 (-4.76%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$1.20 0.00 (0.00%) As of 01/31/2025 07:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MIRA vs. THTX, BLUE, PMVP, QNCX, IPSC, IKNA, MRSN, CLSD, APLT, and CNTXShould you be buying MIRA Pharmaceuticals stock or one of its competitors? The main competitors of MIRA Pharmaceuticals include Theratechnologies (THTX), bluebird bio (BLUE), PMV Pharmaceuticals (PMVP), Quince Therapeutics (QNCX), Century Therapeutics (IPSC), Ikena Oncology (IKNA), Mersana Therapeutics (MRSN), Clearside Biomedical (CLSD), Applied Therapeutics (APLT), and Context Therapeutics (CNTX). These companies are all part of the "pharmaceutical products" industry. MIRA Pharmaceuticals vs. Theratechnologies bluebird bio PMV Pharmaceuticals Quince Therapeutics Century Therapeutics Ikena Oncology Mersana Therapeutics Clearside Biomedical Applied Therapeutics Context Therapeutics MIRA Pharmaceuticals (NASDAQ:MIRA) and Theratechnologies (NASDAQ:THTX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership, community ranking and risk. Is MIRA or THTX more profitable? MIRA Pharmaceuticals has a net margin of 0.00% compared to Theratechnologies' net margin of -3.75%. Theratechnologies' return on equity of 0.00% beat MIRA Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets MIRA PharmaceuticalsN/A -337.44% -280.58% Theratechnologies -3.75%N/A -4.31% Do analysts prefer MIRA or THTX? MIRA Pharmaceuticals presently has a consensus price target of $14.00, indicating a potential upside of 1,066.67%. Given MIRA Pharmaceuticals' stronger consensus rating and higher possible upside, equities research analysts plainly believe MIRA Pharmaceuticals is more favorable than Theratechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MIRA Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Theratechnologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor MIRA or THTX? Theratechnologies received 26 more outperform votes than MIRA Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave MIRA Pharmaceuticals an outperform vote while only 52.73% of users gave Theratechnologies an outperform vote. CompanyUnderperformOutperformMIRA PharmaceuticalsOutperform Votes3100.00% Underperform VotesNo VotesTheratechnologiesOutperform Votes2952.73% Underperform Votes2647.27% Which has more volatility and risk, MIRA or THTX? MIRA Pharmaceuticals has a beta of 2.12, indicating that its stock price is 112% more volatile than the S&P 500. Comparatively, Theratechnologies has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Which has preferable valuation and earnings, MIRA or THTX? MIRA Pharmaceuticals has higher earnings, but lower revenue than Theratechnologies. Theratechnologies is trading at a lower price-to-earnings ratio than MIRA Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMIRA PharmaceuticalsN/AN/A-$11.98M-$0.56-2.14Theratechnologies$81.76M0.81-$23.96M-$0.10-14.40 Does the media prefer MIRA or THTX? In the previous week, Theratechnologies had 2 more articles in the media than MIRA Pharmaceuticals. MarketBeat recorded 3 mentions for Theratechnologies and 1 mentions for MIRA Pharmaceuticals. MIRA Pharmaceuticals' average media sentiment score of 1.89 beat Theratechnologies' score of 1.59 indicating that MIRA Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment MIRA Pharmaceuticals Very Positive Theratechnologies Very Positive Do insiders and institutionals have more ownership in MIRA or THTX? 35.2% of MIRA Pharmaceuticals shares are owned by institutional investors. 6.7% of MIRA Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. SummaryMIRA Pharmaceuticals beats Theratechnologies on 11 of the 17 factors compared between the two stocks. Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MIRA vs. The Competition Export to ExcelMetricMIRA PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$18.88M$6.88B$5.58B$9.12BDividend YieldN/A2.90%5.31%3.99%P/E RatioN/A4.5158.9914.21Price / SalesN/A320.231,258.0383.19Price / CashN/A73.5045.9637.70Price / Book4.005.275.124.71Net Income-$11.98M$136.98M$111.17M$224.24M7 Day Performance5.26%-0.59%2.37%-0.17%1 Month Performance5.26%0.18%3.19%0.60%1 Year Performance25.00%7.68%24.69%20.43% MIRA Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MIRAMIRA Pharmaceuticals2.499 of 5 stars$1.20-4.8%$14.00+1,066.7%+27.7%$18.88MN/A0.002Gap UpTHTXTheratechnologiesN/A$1.63-5.1%N/A-7.1%$73.80M$81.76M-16.05140Short Interest ↓News CoveragePositive NewsBLUEbluebird bio2.3438 of 5 stars$7.56-3.1%$49.14+550.5%-62.0%$73.77M$29.50M-0.20520Short Interest ↓Positive NewsPMVPPMV Pharmaceuticals3.1588 of 5 stars$1.43+4.0%$5.50+286.0%-19.3%$73.74MN/A-1.4350Positive NewsQNCXQuince Therapeutics2.8053 of 5 stars$1.68+5.7%$9.50+465.5%+29.8%$73.48MN/A-1.3560News CoveragePositive NewsIPSCCentury Therapeutics2.6908 of 5 stars$0.87-3.9%$10.00+1,056.1%-80.8%$73.47M$2.68M-0.47170Short Interest ↑IKNAIkena Oncology3.0546 of 5 stars$1.51+0.3%$3.00+99.3%+10.4%$72.63M$659,000.00-1.2270Positive NewsMRSNMersana Therapeutics4.1821 of 5 stars$0.59-7.8%$5.57+839.5%-80.7%$71.65M$36.85M-0.95150CLSDClearside Biomedical2.5236 of 5 stars$0.93-0.4%$5.33+476.0%-25.6%$70.08M$8.23M-2.0530APLTApplied Therapeutics4.4304 of 5 stars$0.59-7.0%$6.10+926.9%-81.3%$69.58M$9.99M-0.3730Short Interest ↑CNTXContext Therapeutics2.7496 of 5 stars$0.91+1.0%$6.33+595.2%-10.5%$68.32MN/A-1.007Positive News Related Companies and Tools Related Companies Theratechnologies Competitors bluebird bio Competitors PMV Pharmaceuticals Competitors Quince Therapeutics Competitors Century Therapeutics Competitors Ikena Oncology Competitors Mersana Therapeutics Competitors Clearside Biomedical Competitors Applied Therapeutics Competitors Context Therapeutics Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MIRA) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIRA Stock Alerts